Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Bladder Cancer
Interventions
GENETIC

loss of heterozygosity analysis

GENETIC

microarray analysis

GENETIC

microsatellite instability analysis

OTHER

cytology specimen collection procedure

OTHER

laboratory biomarker analysis

PROCEDURE

computed tomography

PROCEDURE

cystoscopy

Trial Locations (13)

10021

Memorial Sloan-Kettering Cancer Center, New York

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

29572

Grand Strand Urology, LLP, Myrtle Beach

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

77030

Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston

94305-5824

Stanford Cancer Center, Stanford

60637-1470

University of Chicago Cancer Research Center, Chicago

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

48109-0942

University of Michigan Comprehensive Cancer Center, Ann Arbor

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

M4N 3M5

Edmond Odette Cancer Centre at Sunnybrook, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00095589 - Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer | Biotech Hunter | Biotech Hunter